Literature DB >> 11784989

[Ischemia of the vertebrobasilar territory: mechanisms and practical considerations].

G Saposnik1, L R Caplan.   

Abstract

OBJECTIVE: We first review historic, anatomic, and epidemiological aspects involving the vertebrobasilar territory ischemia. We describe the development of ideas regarding the stroke mechanisms and treatment in the posterior circulation. Key authors and their contributions are also mentioned. DEVELOPMENT: Several new diagnostic and therapeutic strategies have emerged during the last few decades in cerebrovascular disease. The comprehension of the ischemic stroke in the posterior circulation is more difficult than carotid circulation. Thus, vertebrobasilar stroke represents a microcosm. Several mechanisms may explain the ischemic process (large artery disease, penetrating vessel disease, cardioembolism, unusual causes of stroke, and combined or undetermined causes). One of the most common is large artery atherosclerosis. Transient ischemic attacks, usually stereotyped, may be the clue for the earliest recognition. Correct diagnosis may improve the chance of effective therapy. Some practical considerations may help to identify the underlying cause of the stroke.
CONCLUSIONS: The prognosis in patients with vertebrobasilar ischemia depends on: a) the mechanism of the stroke, b) site of the vessel occlusion, c) thrombus propagation, d) collateral circulation, e) hemodynamic (hypertension, cardiac output, etc.), and hemorreologic factors (viscosity, hypercoagulable state, etc.), f) neurologic status, g) time to treatment. The accurate the diagnosis of the mechanism, the better the prognosis.

Entities:  

Mesh:

Year:  2001        PMID: 11784989

Source DB:  PubMed          Journal:  Rev Neurol        ISSN: 0210-0010            Impact factor:   0.870


  1 in total

1.  Cerebral collateral circulation in carotid artery disease.

Authors:  José R Romero; Aleksandra Pikula; Thanh N Nguyen; Yih Lin Nien; Alexander Norbash; Viken L Babikian
Journal:  Curr Cardiol Rev       Date:  2009-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.